Characterization of new specific copper chelators as potential drugs for the treatment of Alzheimer's disease.
about
Potential toxicity of engineered nanoparticles in mammalian germ cells and developing embryos: treatment strategies and anticipated applications of nanoparticles in gene deliveryMetals and Neuronal Metal Binding Proteins Implicated in Alzheimer's DiseaseThe Necessity of Having a Tetradentate Ligand to Extract Copper(II) Ions from Amyloids.Antimalarial and antimicrobial activities of 8-Aminoquinoline-Uracils metal complexes.Ultraviolet light triggers the conversion of Cu2+-bound Aβ42 aggregates into cytotoxic species in a copper chelation-independent manner.Developing drugs targeting transition metal homeostasis.Transfer of Copper from an Amyloid to a Natural Copper-Carrier Peptide with a Specific Mediating Ligand.How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study.Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals.Electrochemiluminescence of Supramolecular Nanorods and Their Application in the "On-Off-On" Detection of Copper Ions.N4-Tetradentate chelators efficiently regulate copper homeostasis and prevent ROS production induced by copper-amyloid-β1-16, even in the presence of an excess of zinc.The serum copper/zinc ratio in childhood and educational attainment: a population-based study
P2860
Q26744195-2145F59E-2BD0-4524-9266-A06C6A19008EQ26765782-74C505E1-DE65-4812-A715-F3B9A001E26BQ35236746-E47CB5C9-71C0-4BED-A3BA-381CC642DBF4Q36806815-64A6626D-F448-4723-9BE4-E48FA76E574DQ38836859-32612321-D928-4ECA-A7DE-71C4913C2FBBQ39063848-0E544E7B-837A-4760-875D-C913F5E8FAAEQ40484991-254EA59F-A4CC-44A0-A7B5-9CD5393D68C0Q42363354-9D461322-9BFE-4EF3-BA24-1CB0C5B60BB6Q50288922-27B31DBE-EB22-4172-A3D8-E26952FCF818Q50856780-051CCD9A-C3DE-4662-9306-E16C8BA75EF9Q52691749-FAFE5CE1-F773-4502-875F-4846B7087C72Q59265611-2A6AE151-B26F-42C4-946B-703F6CE24D1F
P2860
Characterization of new specific copper chelators as potential drugs for the treatment of Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Characterization of new specif ...... atment of Alzheimer's disease.
@en
Characterization of new specif ...... atment of Alzheimer's disease.
@nl
type
label
Characterization of new specif ...... atment of Alzheimer's disease.
@en
Characterization of new specif ...... atment of Alzheimer's disease.
@nl
prefLabel
Characterization of new specif ...... atment of Alzheimer's disease.
@en
Characterization of new specif ...... atment of Alzheimer's disease.
@nl
P2860
P50
P356
P1476
Characterization of new specif ...... atment of Alzheimer's disease.
@en
P2093
Alix Sournia-Saquet
Michel Nguyen
P2860
P304
P356
10.1002/CHEM.201402143
P407
P577
2014-05-05T00:00:00Z